Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 25.70
-0.40 (-1.53%)
Jun 18, 2026, 1:30 PM CST
Genovate Biotechnology Market Cap
Genovate Biotechnology has a market cap or net worth of 2.92 billion as of June 18, 2026. Its market cap has increased by 23.36% in one year.
Market Cap
2.92B
Enterprise Value
1.81B
Revenue
471.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.70
Market Cap Chart
Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 2.92B, an increase of 339.74%. That is a compound annual growth rate of 8.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.92B | -7.22% |
| Dec 31, 2025 | 3.15B | 35.56% |
| Dec 31, 2024 | 2.32B | -20.11% |
| Dec 29, 2023 | 2.91B | -17.02% |
| Dec 30, 2022 | 3.51B | 31.05% |
| Dec 30, 2021 | 2.68B | -15.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.23B |
| Shine-On BioMedical | 3.18B |
| Energenesis Biomedical CO.,LTD. | 3.17B |
| BioGend Therapeutics | 3.14B |
| BRIM Biotechnology | 3.00B |
| Apex Biotechnology | 2.92B |
| GlycoNex Incorporation | 2.82B |
| HeXun Biosciences | 2.75B |